# |
Query |
Results |
S28 |
S15 AND S27 |
13 |
S27 |
S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 |
954,451 |
S26 |
TX allocat* random* |
4,243 |
S25 |
(MH "Quantitative Studies") |
13,282 |
S24 |
(MH "Placebos") |
9,173 |
S23 |
TX placebo* |
33,620 |
S22 |
TX random* allocat* |
4,243 |
S21 |
(MH "Random Assignment") |
38,985 |
S20 |
TX randomi* control* trial* |
85,907 |
S19 |
TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) |
763,614 |
S18 |
TX clinic* n1 trial* |
170,899 |
S17 |
PT Clinical trial |
77,668 |
S16 |
(MH "Clinical Trials+") |
186,062 |
S15 |
S7 AND S14 |
18 |
S14 |
S8 OR S9 OR S10 OR S11 OR S12 OR S13 |
1,216 |
S13 |
TX rHCG |
6 |
S12 |
TX uHCG |
1 |
S11 |
TX HCG |
740 |
S10 |
TX Human chorionic gonadotropin |
578 |
S9 |
TX Human chorionic gonadotrophin |
170 |
S8 |
(MM "Gonadotropins, Chorionic") |
498 |
S7 |
S1 OR S2 OR S3 OR S4 OR S5 OR S6 |
175 |
S6 |
TX (oocyte* N3 prim*) |
7 |
S5 |
TX (oocyte* N3 activat*) |
11 |
S4 |
TX (oocyte* N3 maturation) |
64 |
S3 |
TX (in vivo N3 matur*) |
26 |
S2 |
TX IVM |
38 |
S1 |
TX in vitro maturation |
95 |